Trial · NCT02488759
Results by group93
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 93
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Neoadjuvant: Number of Participants With Drug-Related Select Adverse Events (AEs) | Neoadjuvant | Endocrine AEs | 3 | Participants | |
| Neoadjuvant: Number of Participants With Drug-Related Select Adverse Events (AEs) | Neoadjuvant | Gastrointestinal AEs | 4 | Participants | |
| Neoadjuvant: Number of Participants With Drug-Related Select Adverse Events (AEs) | Neoadjuvant | Hepatic AEs | 3 | Participants | |
| Neoadjuvant: Number of Participants With Drug-Related Select Adverse Events (AEs) | Neoadjuvant | Pulmonary AEs | 0 | Participants | |
| Neoadjuvant: Number of Participants With Drug-Related Select Adverse Events (AEs) | Neoadjuvant | Renal AEs | 0 | Participants | |
| Neoadjuvant: Number of Participants With Drug-Related Select Adverse Events (AEs) | Neoadjuvant | Skin AEs | 9 | Participants | |
| Neoadjuvant: Number of Participants With Drug-Related Select Adverse Events (AEs) | Neoadjuvant | Hypersensitivity/Infusion Reaction AEs | 5 | Participants | |
| Neoadjuvant: Number of Participants With Drug-Related Serious Adverse Events (SAEs) | Neoadjuvant | 6 | Participants | ||
| Neoadjuvant: Rate of Surgery Delay | Neoadjuvant | HPV positive SCCHN | 0 | 95% Confidence Interval 0 to 13.7 | Percentage of participants |
| Neoadjuvant: Rate of Surgery Delay | Neoadjuvant | HPV negative SCCHN | 0 | 95% Confidence Interval 0 to 13.7 | Percentage of participants |
| Neoadjuvant: Rate of Surgery Delay | Neoadjuvant | Cervical Carcinoma | 7.7 | 95% Confidence Interval 0.2 to 36.0 | Percentage of participants |
| Neoadjuvant: Rate of Surgery Delay | Neoadjuvant | Vaginal/Vulvar Carcinoma | 0 | 95% Confidence Interval 0.0 to 26.5 | Percentage of participants |
| Neoadjuvant: Rate of Surgery Delay | Neoadjuvant | Merkel Cell Carcinoma | 2.7 | 95% Confidence Interval 0.1 to 14.2 | Percentage of participants |
| Metastatic: Investigator-Assessed Objective Response Rate (ORR) | Metastatic Monotherapy | EBV positive related gastric cancer | 14.3 | 95% Confidence Interval 1.8 to 42.8 | Percentage of participants |
| Metastatic: Investigator-Assessed Objective Response Rate (ORR) | Metastatic Monotherapy | HPV positive SCCHN | 11.5 | 95% Confidence Interval 2.4 to 30.2 | Percentage of participants |
| Metastatic: Investigator-Assessed Objective Response Rate (ORR) | Metastatic Combo A | HPV positive SCCHN | 31.0 | 95% Confidence Interval 17.6 to 47.1 | Percentage of participants |
| Metastatic: Investigator-Assessed Objective Response Rate (ORR) | Metastatic Combo C | HPV positive SCCHN | 0 | 95% Confidence Interval 0.0 to 36.9 | Percentage of participants |
| Metastatic: Investigator-Assessed Objective Response Rate (ORR) | Metastatic Combo A | Other anogenital HPV associated cancers | 34.8 | 95% Confidence Interval 16.4 to 57.3 | Percentage of participants |
| Metastatic: Investigator-Assessed Objective Response Rate (ORR) | Metastatic Combo B | Other anogenital HPV associated cancers | 28.6 | 95% Confidence Interval 11.3 to 52.2 | Percentage of participants |
| Metastatic: Investigator-Assessed Objective Response Rate (ORR) | Metastatic Combo D | SCCHN I-O naive | 16.7 | 95% Confidence Interval 0.4 to 64.1 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02488759/results